Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer.

Cancers (Basel) · 2023 · PMC10252021 · PMID 37296893

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Although no differences were detected in OS, there was a positive trend towards benefit for patients with combined positive score (CPS ≥ 10) treated with pembrolizumab.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.